(Q39235855)

10 September 2017

1 reference

title

Public health policy, community services, and outcomes for patients with schizophrenia (English)

1 reference

10 September 2017

0 references

1 reference

Lehman AF

1

1 reference

10 September 2017

publication date

1 March 1998

1 reference

Psychiatric Clinics of North America

10 September 2017

published in

1 reference

10 September 2017

volume

21

1 reference

10 September 2017

issue

1

1 reference

10 September 2017

page(s)

221-231

1 reference

Practice parameters for the assessment and treatment of children and adolescents with schizophrenia. American Academy of Child and Adolescent Psychiatry

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970368-3

7 January 2021

Clinical services research

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970368-3

7 January 2021

Clozapine: efficacy and safety

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970368-3

7 January 2021

Conventional antipsychotic medications for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970368-3

7 January 2021

Family interventions for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970368-3

7 January 2021

Rehabilitative day treatment vs. supported employment: I. Vocational outcomes.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970368-3

7 January 2021

Family psychoeducation, social skills training, and maintenance chemotherapy in the aftercare treatment of schizophrenia. II. Two-year effects of a controlled study on relapse and adjustment. Environmental-Personal Indicators in the Course of Schizo

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970368-3

7 January 2021

Medical comorbidity in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970368-3

7 January 2021

Adjunctive treatments in schizophrenia: pharmacotherapies and electroconvulsive therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970368-3

7 January 2021

Vocational rehabilitation in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970368-3

7 January 2021

Measuring quality of life in a reformed health system.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970368-3

7 January 2021

Multiple-Family Groups and Psychoeducation in the Treatment of Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970368-3

7 January 2021

A selective review of recent North American long-term followup studies of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970368-3

7 January 2021

Research update on the psychosocial treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970368-3

7 January 2021

The costs of schizophrenia. Assessing the burden.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970368-3

7 January 2021

Psychological interventions for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970368-3

7 January 2021

Assertive community treatment and case management for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970368-3

7 January 2021

Risperidone: efficacy and safety

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970368-3

7 January 2021

Measuring the fidelity of implementation of a mental health program model.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970368-3

7 January 2021

10.1016/S0193-953X(05)70368-3

Identifiers

DOI

1 reference

10 September 2017

1 reference